药物对比
Canagliflozin vs Rosiglitazone
比较Canagliflozin与Rosiglitazone作为2型糖尿病的治疗选择，包括机制、获益、风险，以及哪种药物可能更适合您。
此页面暂无可用的对比维度。
临床背景
This comparison typically arises for type 2 diabetes patients considering alternatives after metformin or weighing SGLT2 inhibitors against TZDs based on cardiovascular or renal status.
结论
Canagliflozin may be preferable for those with heart or kidney disease due to proven benefits, whereas Rosiglitazone suits insulin-resistant patients, but individual factors decide the winner.
全部药物对比